Migraine Awareness Week 2025: Insights from BMC Series Journals
Published in General & Internal Medicine and Public Health
Migraine isn’t just a headache; it is a complex neurological disorder that affects over one billion people worldwide and ranks among the leading causes of disability. Its symptoms including intense head pain, visual disturbances, nausea, fatigue, and sensitivity to light or sound can severely disrupt daily life, making it difficult to work, study, or maintain relationships. Despite this global impact, migraine remains under-recognized, under-diagnosed, and under-treated in many healthcare systems.
In this blog, we spotlight recent publications from BMC Series journals, including BMC Neurology and BMC Public Health, that highlight three critical aspects of living with migraine: the stigma faced by individuals with migraine, the population-level burden and unmet needs in care, and the influence of lifestyle factors in the digital era on migraine severity.
BMC Neurology - Stigmatizing attitudes toward people with migraine by people without active migraine: results of the OVERCOME (US) study
Migraine is not only a disabling neurological disorder but also one that carries stigma. Because it is an “invisible” condition, many people with migraine feel dismissed by the family and the society who may consider their condition insignificant. This external stigma adds to the emotional and social burden of living with migraine.
A recent study published in BMC Neurology explored stigmatizing attitudes towards people with migraine using data from the ObserVational survey of the Epidemiology, tReatment and Care Of MigrainE (OVERCOME) US study, a population-based web survey. The study found that 70% of people without active migraine endorsed at least one stigmatizing attitude toward those with migraine. Stigmatizing attitudes were more common among people who had a history of migraine or close contact with someone who had migraine. These findings show that people with migraine face stigma from both those who experience migraine and those who do not, highlighting the importance of raising awareness and building supportive environments.

©Fizkes/Getty Images/iStock
BMC Public health - The epidemiology and unmet need of migraine in five european countries: results from the national health and wellness survey
Migraine is the second leading cause of disability worldwide and affects more than 1.1 billion people. Despite its high prevalence, migraines often remain under-diagnosed and under-treated, leading to poor health outcomes and increased economic burden.
A recent study published in BMC Public Health assessed the burden of migraine in five European countries - France, Germany, the UK, Italy, and Spain, using patient-reported data from the National Health and Wellness Survey. The study found that migraine affects about 11.5% of adults, with Spain reporting the highest rates. The highest prevalence was seen among adults aged 30–39 years, and women were twice as likely as men to experience migraine. Nearly one-fourth of diagnosed respondents reported more than four monthly migraine days, and over half had more than four monthly headache days. Despite available treatments, most patients were managed by primary care physicians with a strong reliance on painkillers, reflecting high rates of medication overuse and gaps in referral and specialist care. These results highlight a significant treatment gap in Europe and the need for improved management strategies.

©SARINYAPINNGAM/Getty Images/iStock
BMC public health - Internet use May be associated with the severity of headache in migraine patients: results from a Hungarian tertiary headache center
Along with stress, poor posture, and diet, digitalization has emerged as a lifestyle factor that may influence migraine. Excessive use of screens and internet-based activities has been linked to both the frequency and severity of migraine attacks, with patterns resembling behavioral addiction.
A recent questionnaire-based cross-sectional study from Hungary, published in BMC Public Health, examined how internet use patterns affect migraine severity. The study found that individuals who used the internet between 9 pm and midnight were more likely to experience severe migraine attacks. Nighttime use, often a sign of internet addiction, was also associated with sleep deprivation and insomnia. Online gaming was particularly linked with more severe headaches. These findings suggest that reducing late-night screen time and prioritizing healthy sleep habits may help prevent or lessen migraine severity. The study highlights how digital habits are an important part of migraine management in modern life.

©Motortion/Getty Images/iStock
Making the Invisible Visible
The 2025 campaign theme for Migraine Awareness, “I AM (IN)VISIBLE,” is a powerful reminder that although migraine cannot be seen, its effects are profound. Research from the BMC Series underscores the urgent need to raise awareness and create supportive environments for people with migraine, helping reduce its global burden and improve the quality of life for millions.
Follow the Topic
-
BMC Public Health
An open access, peer-reviewed journal that considers articles on the epidemiology of disease and the understanding of all aspects of public health.
-
BMC Neurology
This is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of neurological disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
Related Collections
With Collections, you can get published faster and increase your visibility.
Facial nerve disorders and diseases
BMC Neurology is now welcoming submissions to a new Collection focused on facial nerve disorders and diseases, highlighting recent advances in their underlying mechanisms, diagnostic advancements, and treatment options aimed at improving patient care and outcomes.
Facial nerve disorders such as facial palsies, hemifacial spasm, and peripheral nerve injuries can stem from various causes, including viral infections, trauma, neoplasms, or vascular compression. These conditions not only affect facial function and expression but also deeply influence psychological well-being and quality of life. Recent developments — ranging from refined surgical techniques and real-time intraoperative monitoring to evidence-based rehabilitation approaches (e.g., neuromuscular retraining, mirror therapy) and regenerative therapies, as well as emerging biomarkers — offer new hope for more effective and personalized care.
We encourage submissions that offer clinical insights, novel research findings, and technological advances in the diagnosis and treatment of facial nerve disorders.
Topics of interest to this Collection include, but are not limited to:
•Advances in facial palsy treatment
•The role of microvascular surgery
•Intraoperative neurophysiological monitoring techniques
•Novel and improved facial nerve grading systems in clinical practice
•Mechanisms underlying hemifacial spasm
•Regenerative therapies for facial nerve injuries
•Novel biomarkers as prognostic factors of facial nerve disorders
•Personalized treatment strategies
•Effect of facial nerve disorders on social interactions
•Home-training and tele-rehabilitation for facial nerve disorders
•Rehabilitation approaches for facial paralysis (e.g., neuromuscular retraining, mirror therapy, synkinesis reduction strategies, electrical stimulation)
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: May 20, 2026
Unveiling biomarkers in neurological diseases
BMC Neurology is now welcoming submissions to a new Collection on biomarkers of neurological diseases and their potential in understanding, diagnosing, and managing various neurological conditions. By advancing our understanding of these biomarkers, this research aims to facilitate early intervention strategies and personalized treatment approaches, ultimately improving outcomes for patients affected by neurological disorders.
Neurological diseases, including neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis, pose significant challenges to healthcare systems worldwide. Biomarkers play a crucial role in the diagnosis and management of these conditions, offering insights into disease progression, potential therapeutic targets, and individual patient responses to treatment.
Recent advances in neuroimaging, genetic profiling, and proteomics have significantly enhanced our capacity to identify potential biomarkers that can facilitate the understanding of disease mechanisms and trajectories.
As research in this field continues, we may witness the emergence of novel biomarkers that enable the early detection of neurological diseases long before clinical symptoms arise.
Topics of interest to this Collection include, but are not limited to:
•Novel biomarkers for early detection and diagnosis of neurological diseases
•Advancements in MRI, PET, or CT-based imaging biomarkers
•Neurofilament proteins as biomarkers to diagnose neurodegenerative diseases
•Inflammatory markers as predictors of neurological disease progression and severity
•The role of non-invasive biomarkers in neurology
•Challenges and opportunities in translating biomarker research to clinical practice
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Jun 03, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in